Conference Day One | Tuesday, November 19

For full session descriptions, download the 2025 event guide:

VIEW THE EVENT GUIDE

8:00 am Registration & Coffee

8:50 am Chair’s Opening Remarks

Rethinking Donor Profiles & Variability to Improve Therapeutic Outcomes

9:00 am Fireside Chat: What Does Variability Mean for Allogeneic Cell Therapy Production?

  • Stacey Cranert Senior Director, Immuno-Oncology, Genentech
  • Jamie Goldman Logistics Program Manager, Orca Bio
  • Henri Bayle Chief Scientific & Development Officer, Co-founder, NKILT Therapeutics

9:45 am What Makes a Super Donor? Rethinking Selection Through Immune Function & Lifestyle

  • Tracy Ryan Co-Founder & Chief Communications Officer, NKore Biotherapeutics

10:15 am Managing Intra-Donor Variability to Promote Consistent Cell Therapy Outputs

  • Hubert Tseng Principal Scientist, Immuno-Oncology, Genentech

10:45 am Morning Break & Speed Networking

Achieving Scalable Cell Therapies by Optimizing Donor Selection & Function

11:45 am Maximizing Process Yield Through Understanding Donor Variability

12:15 pm Assessing Donor-Dependent Variability in NK Cell Expansion & Function

12:45 pm Lunch Break

Synopsis

Private lunch hosted by BioIVT, please inquire at info@hansonwade.com for more information.

Harmonizing Language & Technology to Strengthen Donor Selection & Product Consistency

1:45 pm Roundtable Discussion: Bridging the Gap on Donor Variability Through Clear Communication & Better Data Use

  • Aaron Goldman Director, Instructor in Medicine, Mass General Brigham

2:30 pm Overcoming Donor Variability with Computational Predictive Tools

3:00 pm Afternoon Break & Networking

Leveraging Novel Discoveries & Techniques to Identify High-Performing Donors

4:00 pm Identifying the Optimal Gamma-Delta Donor Through a Strategic Screening Approach

  • Jeff Liter President & Chief Executive Officer, Luminary Therapeutics

4:30 pm Peanut Butter & Jelly – Sandwiching Stem Cells & Engineered Immune Effector Cells from Same Donor

  • Parveen Shiraz Physician-Scientist Instructor, Division of Blood & Marrow Transplantation/Cell Therapy (BMT/CT), Stanford University

5:00 pm End of Conference Day One

SPEAKERS
VIEW THE PROGRAM
DAY TWO